Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Executive summary of the Clinical Guidelines of Pharmacotherapy for Neuropathic Pain: second edition by the Japanese Society of Pain Clinicians
Masahiko Sumitani, Tetsuya Sakai, Yoichi Matsuda, et al.
Journal of Anesthesia (2018) Vol. 32, Iss. 3, pp. 463-478
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

A Comprehensive Algorithm for Management of Neuropathic Pain
D. Bates, B. C. Schultheis, Michael Hanes, et al.
Pain Medicine (2019) Vol. 20, Iss. Supplement_1, pp. S2-S12
Open Access | Times Cited: 313
Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations
Dan Ziegler, Solomon Tesfaye, Vincenza Spallone, et al.
Diabetes Research and Clinical Practice (2021) Vol. 186, pp. 109063-109063
Open Access | Times Cited: 123
A Targeted Approach to Post-Mastectomy Pain and Persistent Pain following Breast Cancer Treatment
Philip Chang, Arash Asher, Sean R. Smith
Cancers (2021) Vol. 13, Iss. 20, pp. 5191-5191
Open Access | Times Cited: 37
Safety and Efficacy of Mirogabalin for Peripheral Neuropathic Pain: Pooled Analysis of Two Pivotal Phase III Studies
Jitsu Kato, Masayuki Baba, Masanori Kuroha, et al.
Clinical Therapeutics (2021) Vol. 43, Iss. 5, pp. 822-835.e16
Open Access | Times Cited: 25
Efficacy and safety of add-on mirogabalin to conventional therapy for the treatment of peripheral neuropathic pain after thoracic surgery: the multicenter, randomized, open-label ADMIT-NeP study
Takuro Miyazaki, Keitaro Matsumoto, Toshihiko Satō, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Medication recommendations for treatment of lumbosacral radiculopathy: A systematic review of clinical practice guidelines
Morgan R. Price, Kaelyn E. Mead, Diana M. Cowell, et al.
PM&R (2024) Vol. 16, Iss. 10, pp. 1128-1142
Closed Access | Times Cited: 3
Chronic nanocurcumin treatment ameliorates pain-related behavior, improves spatial memory, and reduces hippocampal levels of IL-1β and TNFα in the chronic constriction injury model of neuropathic pain
Sepideh Saffarpour, Atousa Janzadeh, Behnaz Rahimi, et al.
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 877-886
Closed Access | Times Cited: 20
Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study
Takuya Nikaido, Hiroshi Takatsuna, Shunsuke Tabata, et al.
Pain and Therapy (2022) Vol. 11, Iss. 4, pp. 1195-1214
Open Access | Times Cited: 14
Pharmacotherapy for osteoarthritis-related pain: current and emerging therapies
Mengdi Zhang, Zhiqiang Wang, Changhai Ding
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 9, pp. 1209-1227
Closed Access | Times Cited: 2
Analgesic Treatment Approach for Postherpetic Neuralgia: A Narrative Review
Edmundo Gónima Valero, Walter Antanas Sosa Mendoza, Diana A. Sarmiento, et al.
Journal of Pain & Palliative Care Pharmacotherapy (2023) Vol. 37, Iss. 2, pp. 184-193
Closed Access | Times Cited: 6
<p>Mirogabalin in Japanese Patients with Renal Impairment and Pain Associated with Diabetic Peripheral Neuropathy or Post-Herpetic Neuralgia: A Phase III, Open-Label, 14-Week Study</p>
Masayuki Baba, Hiroshi Takatsuna, Norimitsu Matsui, et al.
Journal of Pain Research (2020) Vol. Volume 13, pp. 1811-1821
Open Access | Times Cited: 16
Scope and Applications of Nanomedicines for the Management of Neuropathic Pain
Yaswanth Kuthati, Vaikar Navakanth Rao, Prabhakar Busa, et al.
Molecular Pharmaceutics (2020) Vol. 17, Iss. 4, pp. 1015-1027
Closed Access | Times Cited: 15
Kampo Formulae for the Treatment of Neuropathic Pain ∼ Especially the Mechanism of Action of Yokukansan ∼
Masataka Sunagawa, Yasunori Takayama, Mami Kato, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 13
Safety of mirogabalin and pregabalin in Japanese patients with neuropathic pain: a retrospective cohort study
Rie Nakajima, Nobuhiro Ooba, Miwako Kamei, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 9, pp. 841-848
Open Access | Times Cited: 4
Real‐world safety and efficacy of amenamevir in patients with herpes zoster in Japan: A postmarketing observational study (REWARD)
Shinich Imafuku, Kenta Korematsu, Naoko Mori, et al.
The Journal of Dermatology (2023) Vol. 50, Iss. 10, pp. 1287-1300
Closed Access | Times Cited: 4
Neuropathic pain development and maintenance and its association with motor recovery after cervical spinal cord injury
Kosuke Saita, Masahiko Sumitani, Yurie Koyama, et al.
Journal of Spinal Cord Medicine (2024), pp. 1-8
Closed Access | Times Cited: 1
Modeling an evaluation of the efficacy of the novel neuroanalgesic drug mirogabalin for diabetic peripheral neuropathic pain and postherpetic neuralgia therapy
Li-Mian Hong, Jianmin Liu, Lin Lei, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 197, pp. 106777-106777
Open Access | Times Cited: 1
POST HERPETIC NEURALGIA
Irsyah Dwi Rohmayanti, Shahdevi Nandar Kurniawan
JPHV (Journal of Pain Vertigo and Headache) (2023) Vol. 4, Iss. 1, pp. 1-6
Open Access | Times Cited: 4
MicroRNA-212-3p Attenuates Neuropathic Pain via Targeting Sodium Voltage-gated Channel Alpha Subunit 3 (NaV 1.3)
Yingda Li, Xizhe Zhang, Zhimei Fu, et al.
Current Neurovascular Research (2019) Vol. 16, Iss. 5, pp. 465-472
Closed Access | Times Cited: 11
Expert consensus of the Chinese Association for the Study of Pain on ion channel drugs for neuropathic pain
Hong Xiao, Ke Ma, Dong Huang, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 9, pp. 2100-2109
Open Access | Times Cited: 10
Extracellular signal-regulated kinase phosphorylation enhancement and NaV1.7 sodium channel upregulation in rat dorsal root ganglia neurons contribute to resiniferatoxin-induced neuropathic pain: The efficacy and mechanism of pulsed radiofrequency therapy
Kotaro Hidaka, Toyoaki Maruta, Tomohiro Koshida, et al.
Molecular Pain (2022) Vol. 18
Open Access | Times Cited: 6
Analysis of Japanese nationwide health datasets: association between lifestyle habits and prevalence of neuropathic pain and fibromyalgia with reference to dementia-related diseases and Parkinson’s disease
Yukinori Nagakura, Maya Hayashi, Shunichi Kajioka
Scandinavian Journal of Pain (2023) Vol. 23, Iss. 4, pp. 662-669
Closed Access | Times Cited: 3
Risk of Pregabalin‐Induced Hypoglycemia: Analysis of the Japanese Adverse Drug Event Report Database
Tomoyuki Yamada, Satoru Mitsuboshi, Junko Makino, et al.
The Journal of Clinical Pharmacology (2021) Vol. 62, Iss. 6, pp. 756-761
Closed Access | Times Cited: 7
Comparison of the effects of duloxetine and pregabalin on pain and associated factors in patients with knee osteoarthritis
Özge Gülsüm İlleez, Kübra Neslihan Kurt Oktay, İlknur Aktaş, et al.
Revista da Associação Médica Brasileira (2022) Vol. 68, Iss. 3, pp. 377-383
Open Access | Times Cited: 5
<p>A Cost-Effectiveness Analysis Of Pregabalin For The Treatment Of Patients With Chronic Cervical Pain With A Neuropathic Component In Japan</p>
Manabu Akazawa, Ataru Igarashi, Nozomi Ebata, et al.
Journal of Pain Research (2019) Vol. Volume 12, pp. 2785-2797
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top